All Posts Tagged With: "EC"
(AZN) AstraZeneca Drug Cleared by the European Commission
AstraZeneca (AZN) and its partner Bristol-Myers Squibb (BMY) announced recently that Komboglyze has been approved by the European Commission...
(BMY) Bristol-Myers Squibb Company Reports Solid Quarter
Bristol-Myers Squibb Company’s (BMY) second quarter 2011 earnings (excluding special items) of $0.56 per share surpassed the Zacks Consensus Estimate by $0.01and the year-ago earnings by $0.02. Higher revenues...
(VPHM) ViroPharma Quarterly Earnings Report Misses Due to Higher Expenses
ViroPharma Inc. (VPHM) posted second quarter fiscal 2011 earnings of 36 cents per share, missing the Zacks Consensus Estimate by 3 cents and the year-ago figure by a penny. Despite higher revenues, earnings...
(EC) Roche Holdings Gets FDA Panel View on Avastin
Roche Holdings Ltd. (RHHBY) recently announced that the US Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) has recommended that the agency should withdraw its approval for...
(CHMP) ViroPharma’s Epilepsy Drug Recommended
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recently gave the go ahead to ViroPharma Inc.’s (VPHM) Buccolam (midazolam, oromucosal solution). The company...
(SHPGY) Shire’s Firazyr Earns FDA Panel Backing
Recently, the Pulmonary-Allergy Drugs Advisory Committee of the US Food and Drug Administration (FDA) issued a positive opinion and recommended the US approval of Shire’s (SHPGY) Firazyr (icatibant).
Shire...
(BMY) Bristol-Myers Squibb and Pfizer Report Positive Data on Blood Thinner Apixaban Drug
Recently, Bristol-Myers Squibb Company (BMY) and partner Pfizer (PFE) announced encouraging top line data from a late-stage study (ARISTOTLE:...
(BIIB) Biogen Idec and Partner Elan Announce EU Label Update for Tysabri
Recently, Biogen Idec, Inc. (BIIB) and partner Elan Corporation (ELN) announced that the European Commission (EC) has approved an update...
(VPHM) ViroPharma’s HAE Drug Gets EU Nod
ViroPharma Inc. (VPHM) recently announced that the European Commission (EC) granted Centralized Marketing Authorization to Cinryze for the treatment of hereditary angioedema (HAE).
The drug is indicated...
(BMY) Bristol-Myers Squibb Compan Gets Good News
Bristol-Myers Squibb Company (BMY) received a boost when its blood-thinner Eliquis (apixaban) was cleared by the European Commission (EC) in 27 nations of the European Union (EU) for preventing venous thromboembolic...
(EC) Ecopetrol S.A. – Exploratory Oil and Gas Production Up 14%
Ecopetrol S.A. (EC) estimates are climbing and the company recently laid out its 2010 investment plan, that includes an 11% increase.
Company Description
Ecopetrol...
(BMRN) BioMarin Pharmaceutical Earns Orphan Status From FDA
Recently, BioMarin Pharmaceutical Inc. (BMRN) announced that the U.S. Food and Drug Administration (FDA) granted orphan drug status to its candidate 3,4-diaminopyridine amifampridine phosphate (3,4-DAP),...
(AEG) Investing in ADRs: The Most Powerful Way to Reduce Market Risk
by Dr. Scott Brown, Advisory Panelist
It’s official: You can reduce your investment...